Wound Mgmt Tech (WNDM) 0.0799 $WNDM Wound Management

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wound Mgmt Tech (WNDM) 0.0799 $WNDM

Wound Management Technologies Reports Preliminary Financial Results for the Third Quarter of 2015
ACCESSWIRE - Wed Oct 07, 3:10PM CDT
ADDISON, TX / ACCESSWIRE / October 7, 2015 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced preliminary financial and operating results for the third quarter and nine months ended September 30, 2015.

Wound Management Technologies Elects Mr. James W. Stuckert to the Board of Directors
ACCESSWIRE - Thu Sep 24, 2:58PM CDT
ADDISON, TX / ACCESSWIRE / September 24, 2015 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that Mr. James W. Stuckert was elected to the Board of Directors of the Company at its September 21, 2015 board meeting.

Wound Management Technologies Reports Second Quarter of 2015 Continuing Strong Growth
ACCESSWIRE - Tue Aug 18, 7:30AM CDT
ADDISON, TX / ACCESSWIRE / August 18, 2015 / Wound Management Technologies, Inc. (OTCQB:WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today preliminary financial and operating results for the second quarter of 2015, continuing its strong sales growth.

Wound Management Technologies Receives Investment; Fully Pays Notes to Brookhaven Medical, Inc.; Mr. S. Oden Howell, Jr. Appointed to the Board of Directors
ACCESSWIRE - Thu Jun 18, 7:30AM CDT
ADDISON, TX / ACCESSWIRE / June 18, 2015 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that it has fully paid short term loans due to Brookhaven Medical Inc. This was made possible by investments from existing shareholders.

Wound Management Technologies Reports Amending and Termination of Its Shipping and Consulting Agreement with WellDyne Health
ACCESSWIRE - Thu Jun 11, 8:00AM CDT
ADDISON, TX / ACCESSWIRE / June 11, 2015 / Wound Management Technologies, Inc. (OTCQB:WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced amending and terminating of its Shipping and Consulting Agreement dated September 19, 2013 with WellDyne Health in order to focus on its strategic shift to focus on sales internally.

Wound Management Technologies Reports Record Preliminary Financial Results for the First Quarter of 2015 and Enhanced Sales Team
ACCESSWIRE - Wed Apr 22, 9:12AM CDT
ADDISON, TX / ACCESSWIRE / April 22, 2015 / Wound Management Technologies, Inc. (OTCQB:WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced record preliminary financial and operating results for the first quarter of 2015 and additions to its sales management team.

Wound Management Technologies, Inc. Schedules First Quarter 2015 Earnings Call for Wednesday, April 22, 2015
ACCESSWIRE - Mon Apr 20, 3:30PM CDT
ADDISON, TX / ACCESSWIRE / April 20, 2015 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced it will conduct a quarterly earnings call on Wednesday, April 22, 2015 at 3:00 p.m. CST. Robert Lutz, Jr., CEO, will discuss first quarter 2015 results and provide and update on recent activities. A question and answer session will follow the presentation. Shareholders, analysts and other interested parties may join the call by dialing 1-712-775-7031 passcode 604070847# shortly before 3:00 p.m. CST.

Wound Management Technologies Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2014
ACCESSWIRE - Thu Apr 09, 8:00AM CDT
ADDISON, TX / ACCESSWIRE / April 9, 2015 / Wound Management Technologies, Inc. (OTCQB:WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced its financial and operating results for the fourth quarter and full year ended December 31, 2014.

Wound Management Technologies Exhibits at the American Academy of Orthopaedic Surgeons 2015 Annual Meeting
ACCESSWIRE - Wed Mar 18, 7:30AM CDT
ADDISON, TX / ACCESSWIRE / March 18, 2015 / Wound Management Technologies, Inc. (OTCQB:WNDM) ("Company", an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that its subsidiary, Wound Care Innovations ("WCI", will be an exhibitor at the American Academy of Orthopaedic Surgeons ("AAOS" Annual Meeting on March 24-28, to be held at the Venetian/Sands Expo in Las Vegas, Nevada. Wound Care Innovations will be located at booth #6729.

Wound Management Technologies Expands Internationally with Inaugural Order from Mexico
ACCESSWIRE - Mon Mar 16, 7:30AM CDT
ADDISON, TX / ACCESSWIRE / March 16, 2015 / Wound Management Technologies, Inc. (OTCQB:WNDM) ("Company", an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that Wound Care Innovations ("WCI", a subsidiary of the Company, received its inaugural order from Mexico, where WCI is registered and signed a distribution agreement with VISECA Desarrollo Inmobiliario SA de CA ("VISECA", a healthcare distributor in Mexico. CellerateRX(R) received COFEPRIS approval from the Mexico Ministry of Health.

Wound Management Technologies Reports Preliminary Financial Results For the Fourth Quarter and Year Ended December 31, 2014
ACCESSWIRE - Thu Jan 29, 7:31AM CST
ADDISON, TX / ACCESSWIRE / January 29, 2015 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced preliminary financial and operating results for the fourth quarter and year ended December 31, 2014.

Wound Management Technologies Appoints John Siedhoff to its Board of Directors
ACCESSWIRE - Tue Jan 13, 7:31AM CST
ADDISON, TX / ACCESSWIRE / January 13, 2015 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), announces that the Company has appointed John Siedhoff to its Board of Directors.

Wound Management Technologies Reports Financial Results for the Third Quarter Ended September 30, 2014
ACCESSWIRE - Thu Nov 13, 7:35AM CST
Addison, TX / ACCESSWIRE / November 13, 2014 / Wound Management Technologies, Inc. (OTC QB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced its financial and operating results for the three month period ended September 30, 2014.

Wound Management Technologies Appoints Ronald Goode and Jeffrey Lewis to the Board of Directors
Marketwired - Tue Oct 21, 7:30AM CDT
Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), announces that the Company appointed Ronald Goode and Jeffrey Lewis to the Board of Directors.

Wound Management Technologies' CellerateRX(R) Featured in Clinical Research Session at the Symposium of Advanced Wound Care (SAWC) in Las Vegas, NV
Marketwired - Thu Oct 16, 7:30AM CDT
Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that the product will be featured in an abstract accepted to the clinical research session at the Symposium of Advanced Wound Care (SAWC), which is being held at the Caesars Palace in Las Vegas, NV on October 16th - 18th, 2014.

Markets for Advanced Wound Management Technologies
PR Newswire - Tue Oct 14, 3:38PM CDT
This BCC Research report provides an overview of advanced wound care products, detailed market analyses and discussions of competitive environments. The study includes information about significant products, players, issues and trends and other information affecting the wound care industry.

Wound Management Technologies Appoints Dr. Blaine Farless as Medical Director of the Resorbable Orthopedic Products Subsidiary
Marketwired - Tue Oct 14, 7:30AM CDT
Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that the Company appointed Dr. Blaine Farless as Medical Director of the Resorbable Orthopedic Products subsidiary (ROP).

Wound Management Technologies Launches Free Investor Relations App
Marketwire Canada - Tue Sep 16, 7:30AM CDT
Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patent-protected and FDA-cleared collagen product, CellerateRX(R), today announced that the Company released an investor relations app for the iPhone, iPad and Android mobile devices.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 25

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 19

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 19

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
Ainstein Expands Kansas Operations Amid Sensor Demand Surge

Updated Category News Views 16

Ainstein's Expansion Conquers New Heights in Radar Tech Ainstein just cranked open a whole new chapter right in the heart of Kansas. And believe me, it's not your average ribbon-cutting story. This shiny new facility in Lenexa is locked and loaded to roll out 44,000 radar sensors a year. It's part of a no-nonsense plan to keep up with soaring demand for their tech across...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 80

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 88

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 30

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 5

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 37

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading

Top 5 Most Recently Viewed Articles

Aura Minerals Inc. Successfully Issues New Brazilian Debentures

Updated Category News Views 55

Aura Minerals Inc. Successfully Secures Funding through Debenture Issuance Aura Minerals Inc. (TSX: ORA) has recently made waves in the financial sector by successfully concluding the public offering of its 2nd issuance of debentures. The company announced this development following previous communications made on several dates earlier this year, confirming the completion...

Continue Reading
Emerging Trends in Clinical Trials Matching Software Market

Updated Category News Views 266

Growth of the Clinical Trials Matching Software Market The landscape of clinical trials is continually evolving, with the clinical trials matching software market expected to reach an impressive USD 501.86 million. This expansion points to a noteworthy compound annual growth rate (CAGR) of 13.14% between 2025 and 2032. Significance of AI and EHR Integration Market...

Continue Reading
Greystone Housing Plans Earnings Call to Discuss Q1 Results

Updated Category News Views 155

Greystone Housing to Host Earnings Conference Call Greystone Housing Impact Investors LP (NYSE: GHI) has announced it will be hosting an important earnings conference call for investors. This event is set to take place on a Wednesday at 4:30 p.m. Eastern Time. The focus of the call will be on discussing the financial results from the first quarter of the year....

Continue Reading
Successful Toyota Dealership Sale in the Automotive Market

Updated Category News Views 864

Performance Brokerage Services Facilitates Dealership Transaction Performance Brokerage Services, a leader in dealership buy-sell activities, has announced the successful sale of Premier Toyota. The dealership changed ownership from Robert Fisher to Kevin Wuepper, showcasing the brokerage firm’s expertise in the automotive sector. The Journey of Premier Toyota Founded...

Continue Reading
Investigation Launched into Sealed Air Corporation's Shareholder Deal

Updated Category News Views 193

Understanding the Investigation of Sealed Air Corporation In recent news, the Ademi Firm has initiated a probe into Sealed Air Corporation (NYSE: SEE), focusing on their proposed transaction with CD&R. This investigation is crucial because it centers on possible violations of fiduciary duty and legal requirements by the company’s board. The goal is to ensure that...

Continue Reading